Acting Attorney General Todd Blanche confirmed that the reclassification will place marijuana alongside drugs with lower abuse potential, like ketamine and testosterone, rather than more dangerous substances like heroin. This decision follows an executive order from President Donald Trump aimed at relaxing federal marijuana restrictions. A formal hearing on the reclassification is scheduled for June 26, 2026, to gather expert input on the matter. The announcement has already led to a surge in investor confidence, with shares of major cannabis companies rising significantly.
HEALTHPublished 23 Apr 2026 • Published 1 day ago
US Justice Department Reclassifies Marijuana as Less Dangerous
67% NEUTRAL
The US Department of Justice has announced plans to reclassify marijuana from Schedule I to Schedule III, easing restrictions on FDA-approved and state-licensed medical marijuana. This shift aims to enhance research, reduce tax burdens, and improve funding access for the cannabis industry, reflecting a growing acceptance of marijuana in the US.
Detailed Analysis
SOURCES
11 outlets · 12 articles
TNP-Ethenews.com.pk
TLtribune.com.pk
SCMPscmp.com